INM
NASDAQ · Pharmaceuticals
Inmed Pharmaceuticals Inc
$0.65
-0.05 (-6.66%)
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+5,076.9% upside
Low Target
$24.21
Average Target
$33.65
High Target
$46.15
Current Price
$0.65
Current
$0.65
$0.65
Target
$33.65
$33.65
$24.21
$33.65 avg
$46.15
Scenario Analysis
Bear Case
$24.21
3,624.6%
Low target
Base Case
$33.65
+5,076.9%
Avg target
Bull Case
$46.15
+7,000.0%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$7.98
-91.9% from high
52-Week Low
$0.58
+13.0% from low
Target vs 52W High
$33.65
+321.7% vs high
Next Earnings Report
May 11, 2026
Today
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals